Drug · DIN 02008718
RETISOL-A
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 3, 2015; first marketed December 31, 1993.
- Drug Identification Number (DIN)
- 02008718
- Company (DIN owner)
- Glaxosmithkline IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Cream
- Route
- Topical
- Therapeutic class (ATC)
- Tretinoin, combinations D10AD51
- Class
- Human
- Record last updated
- June 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRETINOIN | 0.05 % | |
| OCTINOXATE | 7.5 % | |
| AVOBENZONE | 2 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 27, 2010: NOC 11423New Drug Submission (NDS) · Manufacturer name change
Other DINs named RETISOL-A
- DIN 02008688 · Cancelled Post Market
- DIN 02008696 · Cancelled Post Market
- DIN 02008726 · Cancelled Post Market